Plain-English translation of NCT06318273 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This study is testing a new drug called to treat advanced prostate cancer that has stopped responding to standard hormone treatments. The medication is given as an IV infusion every three weeks. Researchers want to find the right dose and understand how well this treatment works for men in your situation.
Prostate cancer that becomes resistant to standard hormone therapies is difficult to treat, and men in this situation need new options. This trial is exploring whether this medication might offer another path forward for controlling the disease.
You will receive the medication as an IV infusion once every 21 days. The study has two parts: first, doctors test different doses to find the safest and most effective one; then, more participants receive the selected dose to confirm it works. You'll need to visit a hospital or clinic regularly for blood tests, scans, and medical check-ups throughout the study, which may last up to 3 years. This will involve more frequent appointments than you might have with standard care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States